Glycosylated Hemoglobin A1c Is Associated with Anthropometric Measurements and Tumor Characteristics in Breast Cancer Patients

References

• Taira N, Akiyama I, Ishihara S, et al. Impact of modifiable lifestyle factors on outcomes after breast cancer diagnosis: the Setouchi Breast Cancer Cohort Study. Jpn J Clin Oncol. 2015;45(6):600–602. doi:10.1093/jjco/hyv033
   Web of Science ®Google Scholar
• Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285(7):885–892. doi:10.1001/jama.285.7.885
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674–1685. doi:10.2337/dc10-0666
   PubMed Web of Science ®Google Scholar
• Liao S, Li J, Wei W, et al. Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Asian Pac J Cancer Prev. 2011;12(4):1061–1065.
   PubMed Web of Science ®Google Scholar
• Starup-Linde J, Karlstad O, Eriksen SA, et al. CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis. Curr Drug Saf. 2013;8(5):296–332. doi:10.2174/15748863113086660071
   PubMedGoogle Scholar
• Boyle P, Boniol M, Koechlin A, et al. Diabetes and breast cancer risk: a meta-analysis. Br J Cancer. 2012;107(9):1608–1617. doi:10.1038/bjc.2012.414
   PubMed Web of Science ®Google Scholar
• Cleveland RJ, North KE, Stevens J, Teitelbaum SL, Neugut AI, Gammon MD. The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project. Cancer Causes Control. 2012;23(7):1193–1203. doi:10.1007/s10552-012-9989-7
   PubMed Web of Science ®Google Scholar
• Erickson K, Patterson RE, Flatt SW, et al. Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol. 2011;29(1):54–60. doi:10.1200/JCO.2010.29.3183
   Web of Science ®Google Scholar
• Luo J, Virnig B, Hendryx M, et al. Diabetes, diabetes treatment and breast cancer prognosis. Breast Cancer Res Treat. 2014;148(1):153–162. doi:10.1007/s10549-014-3146-9
   Web of Science ®Google Scholar
• Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B. Diabetes mellitus and breast cancer. Lancet Oncol. 2005;6(2):103–111. doi:10.1016/S1470-2045(05)01736-5
   PubMed Web of Science ®Google Scholar
• Belfiore A, Frasca F. IGF and insulin receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia. 2008;13(4):381–406.
   Web of Science ®Google Scholar
• Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiol Rev. 2015;95(3):727–748. doi:10.1152/physrev.00030.2014
   PubMed Web of Science ®Google Scholar
• Royal Medical Services (RMS). Available from: http://www.jrms.mil.jo/Contents/About_JRMSar.aspx#. Accessed September 8, 2019.
   Google Scholar
• Hou G, Zhang S, Zhang X, Wang P, Hao X, Zhang J. Clinical pathological characteristics and prognostic analysis of 1013 breast cancer patients with diabetes. Breast Cancer Res Treat. 2013;137(3):807–816. doi:10.1007/s10549-012-2404-y
   PubMed Web of Science ®Google Scholar
• Wang XL, Jia CX, Liu LY, Zhang Q, Li YY, Li L. Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China. World J Surg Oncol. 2013;11:71. doi:10.1186/1477-7819-11-71
   Web of Science ®Google Scholar
• Salinas-Martinez AM, Flores-Cortes LI, Cardona-Chavarria JM, et al. Prediabetes, diabetes, and risk of breast cancer: a case-control study. Arch Med Res. 2014;45(5):432–438. doi:10.1016/j.arcmed.2014.06.004
   Web of Science ®Google Scholar
• Sherman S. Defining the menopausal transition. Am J Med. 2005;118(Suppl 12B):3–7. doi:10.1016/j.amjmed.2005.11.002
   PubMedGoogle Scholar
• World Health Organization (WHO). Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation. Geneva. 8–11 December 2008; 2011.
   Google Scholar
• World Health Organization (WHO). Obesity: Preventing and Managing the Global Epidemic, WHO Technical Report Series 894, Geneva, Switzerland; 2000.
   Google Scholar
• Stark A, Stahl MS, Kirchner HL, Krum S, Prichard J, Evans J. Body mass index at the time of diagnosis and the risk of advanced stages and poorly differentiated cancers of the breast: findings from a case-series study. Int J Obes. 2010;34(9):1381–1386. doi:10.1038/ijo.2010.69
   Web of Science ®Google Scholar
• Edge S,Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Handbook from the AJCC Cancer Staging Manual. 7th ed. New York: Springer Verlag; 2010.
   Google Scholar
• Rakha EA, Reis-Filho JS, Baehner F, et al. Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res. 2010;12(4):207. doi:10.1186/bcr2607
   PubMed Web of Science ®Google Scholar
• Stark A, Schultz D, Kapke A, et al. Obesity and risk of the less commonly diagnosed subtypes of breast cancer. Eur J Surg Oncol. 2009;35(9):928–935. doi:10.1016/j.ejso.2008.11.009
   Web of Science ®Google Scholar
• American Diabetes Association. Diabetes overview, diagnosis. 2019. Available from: https://www.diabetes.org/a1c/diagnosis. Accessed September 6, 2019.
   Google Scholar
• Abdel-Maksoud MF, Risendal BC, Slattery ML, Giuliano AR, Baumgartner KB, Byers TE. Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors. Breast Cancer Res Treat. 2012;131(1):169–176. doi:10.1007/s10549-011-1705-x
   Web of Science ®Google Scholar
• International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327–1334. doi:10.2337/dc09-9033
   PubMed Web of Science ®Google Scholar
• Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care. 2011;34(Suppl 2):S184–S190. doi:10.2337/dc11-s216
   PubMed Web of Science ®Google Scholar
• Danese MD, O’Malley C, Lindquist K, Gleeson M, Griffiths RI. An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer. Ann Oncol. 2012;23(7):1756–1765. doi:10.1093/annonc/mdr486
   Web of Science ®Google Scholar
• Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279–2290. doi:10.1016/S0140-6736(12)60283-9
   PubMed Web of Science ®Google Scholar
• Lambe M, Wigertz A, Garmo H, Walldius G, Jungner I, Hammar N. Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer. Cancer Causes Control. 2011;22(8):1163–1171. doi:10.1007/s10552-011-9794-8
   Web of Science ®Google Scholar
• Huang Y, Cai X, Qiu M, et al. Prediabetes and the risk of cancer: a meta-analysis. Diabetologia. 2014;57(11):2261–2269. doi:10.1007/s00125-014-3361-2
   PubMed Web of Science ®Google Scholar
• Onitilo AA, Stankowski RV, Berg RL, et al. Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase. Eur J Cancer Prev. 2014;23(2):76–83. doi:10.1097/CEJ.0b013e32836162aa
   Web of Science ®Google Scholar
• Jordan Cancer Registry. Cancer incidence in Jordan. Available from: https://www.moh.gov.jo/Echobusv3.0/SystemAssets/245e1e7a-a9ab-4fab-b876-832c2af5f340.pdf. Accessed September 8, 2019.
   Google Scholar
• Al Nsour M, Al Kayyali G, Naffa S. Overweight and obesity among Jordanian women and their social determinants. East Mediterr Health J. 2013;19(12):1014–1019.
   Web of Science ®Google Scholar
• Ajlouni K, Khader YS, Batieha A, Ajlouni H, El-Khateeb M. An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complications. 2008;22(5):317–324. doi:10.1016/j.jdiacomp.2007.01.004
   PubMed Web of Science ®Google Scholar
• Genser L, Casella Mariolo JR, Castagneto-Gissey L, Panagiotopoulos S, Rubino F. Obesity, type 2 diabetes, and the metabolic syndrome: pathophysiologic relationships and guidelines for surgical intervention. Surg Clin North Am. 2016;96(4):681–701. doi:10.1016/j.suc.2016.03.013
   Web of Science ®Google Scholar
• Park SW, Lee HL, Doo EY, et al. Visceral obesity predicts fewer lymph node metastases and better overall survival in colon cancer. J Gastrointest Surg. 2015;19(8):1513–1521. doi:10.1007/s11605-015-2834-z
   PubMed Web of Science ®Google Scholar
• Wierup I, Carlsson AC, Wandell P, Riserus U, Arnlov J, Borne Y. Low anthropometric measures and mortality–results from the Malmo Diet and Cancer Study. Ann Med. 2015;47(4):325–331. doi:10.3109/07853890.2015.1042029
   PubMed Web of Science ®Google Scholar
• Jousheghany F, Phelps J, Crook T, Hakkak R. Relationship between level of HbA1C and breast cancer. BBA Clin. 2016;6:45–48. doi:10.1016/j.bbacli.2016.04.005
   PubMedGoogle Scholar
• Sheth J, Shah A, Sheth F, et al. The association of dyslipidemia and obesity with glycated hemoglobin. Clin Diabetes Endocrinol. 2015;1:6. doi:10.1186/s40842-015-0004-6
   Google Scholar
• Hammer MJ, Aouizerat BE, Schmidt BL, Cartwright F, Wright F, Miaskowski C. Glycosylated hemoglobin A1c and lack of association with symptom severity in patients undergoing chemotherapy for solid tumors. Oncol Nurs Forum. 2015;42(6):581–590. doi:10.1188/15.ONF.581-590
   Web of Science ®Google Scholar
• Abrahamson PE, Gammon MD, Lund MJ, et al. General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1871–1877. doi:10.1158/1055-9965.EPI-06-0356
   Web of Science ®Google Scholar
• Healy LA, Ryan AM, Carroll P, et al. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol. 2010;22(4):281–288. doi:10.1016/j.clon.2010.02.001
   Web of Science ®Google Scholar
• Chan DS, Vieira AR, Aune D, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901–1914. doi:10.1093/annonc/mdu042
   PubMed Web of Science ®Google Scholar
• Ayoub NM, Yaghan RJ, Abdo NM, Matalka II, Akhu-Zaheya LM, Al-Mohtaseb AH. Impact of obesity on clinicopathologic characteristics and disease prognosis in pre- and postmenopausal breast cancer patients: a Retrospective Institutional Study. J Obes. 2019;2019:3820759. doi:10.1155/2019/3820759
   Web of Science ®Google Scholar
• van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514–527. doi:10.1093/aje/152.6.514
   PubMed Web of Science ®Google Scholar
• Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335(7630):1134. doi:10.1136/bmj.39367.495995.AE
   PubMed Web of Science ®Google Scholar
• Carmichael AR, Bates T. Obesity and breast cancer: a review of the literature. Breast. 2004;13(2):85–92. doi:10.1016/j.breast.2003.03.001
   Web of Science ®Google Scholar
• Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet. 2014;384(9945):755–765. doi:10.1016/S0140-6736(14)60892-8
   PubMed Web of Science ®Google Scholar
• Palmer JR, Adams-campbell LL, Boggs DA, Wise LA, Rosenberg L. A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev. 2007;16(9):1795–1802. doi:10.1158/1055-9965.EPI-07-0336
   Web of Science ®Google Scholar
• Gravena AAF, Romeiro Lopes TC, Demitto MO, et al. The obesity and the risk of breast cancer among pre and postmenopausal women. Asian Pac J Cancer Prev. 2018;19(9):2429–2436. doi:10.22034/APJCP.2018.19.9.2429
   Google Scholar
• Vona-Davis L, Rose DP, Hazard H, et al. Triple-negative breast cancer and obesity in a rural Appalachian population. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3319–3324. doi:10.1158/1055-9965.EPI-08-0544
   Web of Science ®Google Scholar
• Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197–1209. doi:10.1016/S0140-6736(05)67483-1
   PubMed Web of Science ®Google Scholar
• Bronsveld HK, Jensen V, Vahl P, et al. Diabetes and breast cancer subtypes. PLoS One. 2017;12(1):e0170084. doi:10.1371/journal.pone.0170084
   PubMed Web of Science ®Google Scholar
• Karlin N, Dueck A, Nagi Reddy S, Verona P, Cook C. Implications of breast cancer with diabetes mellitus on patient outcomes and care. Diabetes Manage. 2014;4(5):411–419. doi:10.2217/dmt.14.39
   Google Scholar
• Peairs KS, Barone BB, Snyder CF, et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol. 2011;29(1):40–46. doi:10.1200/JCO.2009.27.3011
   PubMed Web of Science ®Google Scholar
• Griffiths RI, Danese MD, Gleeson ML, Valderas JM. Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-medicare. BMC Cancer. 2012;12:613. doi:10.1186/1471-2407-12-613
   Web of Science ®Google Scholar
• Liao S, Li J, Wang L, et al. Type 2 diabetes mellitus and characteristics of breast cancer in China. Asian Pac J Cancer Prev. 2010;11(4):933–937.
   Google Scholar